Department of Surgery, Daehang Hospital, Seoul, Korea.
Surg Endosc. 2013 Jan;27(1):31-9. doi: 10.1007/s00464-012-2403-4. Epub 2012 Jun 23.
Endoscopic submucosal dissection (ESD) is a very useful endoscopic technique, making it possible to perform en bloc resection regardless of lesion size. Since the introduction of ESD at our hospital, we have performed 1,000 colorectal ESDs during 56 months. The purpose of this study was to evaluate the clinical outcomes of our colorectal ESD experience and to access the efficacy and safety of colorectal ESD.
Between October 2006 and August 2011, we performed ESD on 1,000 consecutive colorectal tumors in 966 patients. We evaluated the clinical outcomes of all said cases.
The mean resected tumor size was 24.1 ± 13.3 (3-145) mm. Our overall endoscopic en bloc resection rate was 97.5% (975/1,000), and our R0 resection rate was 91.2% (912/1,000) respectively. Our perforation rate was 5.3% (53/1,000). Of these 53 perforations, 50 cases were treated through conservative management with/without endoscopic clipping, whereas the remaining 3 patients received laparoscopic operation. Pathological examination showed adenocarcinoma in 37.2% of cases (372/1,000) and neuroendocrine tumors in 11.2% (112/1,000). We recommended additional radical surgery to 82 patients who had a risk of lymph node metastasis. Follow-up colonoscopies were performed on 722 patients. During the median follow-up period of 13 (1-62) months, there were three recurrences (0.4%).
ESD is technically difficult, with a substantial risk of perforation. However, ESD enabled en bloc resection and pathologically complete resection of large colorectal epithelial tumors and submucosal tumors. As experience with the technique increases, ESD may gradually replace piecemeal endoscopic mucosal resection and radical colon resection in the treatment of colorectal tumors.
内镜黏膜下剥离术(ESD)是一种非常有用的内镜技术,无论病变大小,均可实现整块切除。自我院开展 ESD 以来,我们在 56 个月内完成了 1000 例结直肠 ESD。本研究旨在评估我们结直肠 ESD 经验的临床结果,并评估结直肠 ESD 的疗效和安全性。
2006 年 10 月至 2011 年 8 月,我们对 966 例患者的 1000 例连续结直肠肿瘤进行了 ESD。我们评估了所有病例的临床结果。
平均切除肿瘤大小为 24.1±13.3(3-145)mm。我们的内镜整块切除率为 97.5%(975/1000),R0 切除率为 91.2%(912/1000)。穿孔率为 5.3%(53/1000)。其中 53 例穿孔经保守治疗(内镜夹闭或不夹闭)治愈,3 例患者接受腹腔镜手术治疗。病理检查显示腺癌占 37.2%(372/1000),神经内分泌肿瘤占 11.2%(112/1000)。我们建议 82 例有淋巴结转移风险的患者进行额外的根治性手术。722 例患者接受了随访结肠镜检查。在中位随访 13(1-62)个月期间,有 3 例复发(0.4%)。
ESD 技术难度大,穿孔风险高。然而,ESD 使整块切除和病理完全切除大的结直肠上皮肿瘤和黏膜下肿瘤成为可能。随着该技术经验的增加,ESD 可能逐渐取代分片内镜黏膜切除术和结直肠根治术治疗结直肠肿瘤。